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A B S T R A C T   
With a diverse set of neuronal and glial cell populations, Central Nervous System (CNS) has one of the most 
complex structures in the body. Intercellular communication is therefore highly important to coordinate cell-to- 
cell interactions. Besides electrical and chemical messengers, CNS cells also benefit from another communication 
route, what is known as extracellular vesicles, to harmonize their interactions. Extracellular Vesicles (EVs) and 
their subtype exosomes are membranous particles secreted by cells and contain information packaged in the form 
of biomolecules such as small fragments of DNA, lipids, miRNAs, mRNAs, and proteins. They are able to effi-
ciently drive changes upon their arrival to recipient cells. EVs actively participate in all stages of CNS devel-
opment by stimulating neural cell proliferation, differentiation, synaptic formation, and mediating reciprocal 
interactions between neurons and oligodendrocyte for myelination process. The aim of the present review is to 
enlighten the presence and contribution of EVs at each CNS developmental milestone.   
1. Introduction 
Extracellular Vesicles (EVs) were initially thought to function as a 
disposal mechanism carrying cellular waste into extracellular space. 
They are nowadays established as one of the lines of communication 
between cells. 
The name “extracellular vesicle” is a general term used to describe 
three subtypes of vesicles: (i) Microvesicles (ii) Exosomes and (iii) 
Apoptotic bodies. It is important to mention that the terms EVs and 
exosomes are used interchangeably in literature. There is indeed a high 
inconsistency within the field regarding the nomenclature used to 
describe extracellular vesicles. A wide range of terminologies are used in 
literature while no unambiguous definition based on subtype specific 
markers or subtype specific isolation methods is available for the 
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subtypes. (Mora et al., 2016; Yanez-Mo et al., 2015). For example, the 
two terms EVs and exosomes are used interchangeably, and a selection 
for a term seems to be based on authors’ preference (Witwer & Thery, 
2019). The International Society for Extracellular Vesicles (ISEV) has 
proposed a consensus nomenclature in which EVs is a preferred generic 
term to describe lipid bilayer particles that are released by cells and 
unable to replicate due to the lack of functional nucleus (Thery et al., 
2018). In the present review we follow these guidelines, however, when 
discussing individual studies we adopt the terms used by the authors of 
the study. 
The subtypes of EVs are distinguished based on their size, origin of 
formation, content, function, and mechanism of release (Doyle & Wang, 
2019). With a size ranging from 30nm-to 100 nm, exosomes are the 
smallest vesicles followed by microvesicles (100 nm-1000 nm) and 
apoptotic bodies (1000-5000 nm)(Maia et al., 2018). It is important to 
mention that different methods have been proposed to determine di-
ameters and thus there is an overlap between the subclasses of EVs with 
respect to size (Borges et al., 2013; Cocucci & Meldolesi, 2015; EL 
Andaloussi et al., 2013). Therefore, to further characterize EV sub-
populations, researchers usually use methods such as Nano Tracking 
Analysis (NTA) in combination with electron microscopy, flow cytom-
etry or Western blotting of the known EVs markers. 
The different EV subpopulations arise from different biogenetic 
pathways. Apoptotic bodies result from a process that orchestrates the 
demise of the cell and that produces membrane-encapsulated cellular 
fragments that can contain organelles, proteins, DNA and RNA. 
Apoptotic bodies are not homogenous and have a broad size distribution 
(Battistelli & Falcieri, 2020; Xu et al., 2019) Microvesicles are formed by 
direct outward budding of the plasma membrane and can be released 
into the extracellular space by “pinching off” from the cell membrane. 
This process requires cytoskeletal proteins such as actin, microtubules, 
and molecular motors such as dynein, kinesis and myosin as well as a 
collaboration between SNARES, Rab GTPases and tethering factors (Cai 
et al., 2007; Doyle & Wang, 2019; Tricarico et al., 2017). 
As opposed to microvesicles and apoptotic bodies, which have rela-
tively simple biogenetic pathways, exosomes are generated by a com-
plex multistep process that starts with the formation of early endosomes 
that evolve into late endosomes and multivesicular bodies (MVBs) 
containing intraluminal vesicles (ILVs). Early endosomes are formed by 
the invagination of the plasma membrane and gradually mature into late 
endosomes (Doyle & Wang, 2019). Maturation from early to late en-
dosome is mainly mediated by the small GTPases Rab5 and Rab7. In this 
process, which is known as Rab conversion, the depletion of Rab 5, the 
marker of early endosome, is accompanied by the recruitment of Rab7 
on late endosomes (Poteryaev et al., 2010; Rink et al., 2005). ILVs are 
formed by inward budding of the limiting membranes of late endosomes 
(Piper & Katzmann, 2007). Fusion of the limiting membrane of MVBs 
with the plasma membrane leads to the release of ILVs into the extra-
cellular space. ILVs in the extracellular space are termed exosomes 
(Caruso Bavisotto et al., 2019; Minciacchi et al., 2015; van Niel et al., 
2006; Zhang et al., 2019a). The precise mechanisms of cargo sorting into 
ILVs have not been resolved yet but are dependent on the biogenetic 
pathway of ILVs. 
ILVs can be produced by the well-studied endosomal sorting com-
plexes required for transport (ESCRT) dependent pathway. This protein 
machinery consists of four complexes (ESCRT-0,-I,-II,-III) which are 
sequentially recruited on the late endosome membrane (Colombo et al., 
2013; Henne et al., 2011). The two protein subunits of ESCRT-0, Hrs and 
STAM1/2 (Vps27 and Hse1 in yeast) arrange the recruitment of ubiq-
uitinated cargo to the limiting membrane of the endosome where the 
inward budding starts (Henne et al., 2011; Piper & Katzmann, 2007). 
ESCRT-0 then activates the TSG101 containing ESCRT-I complex 
(Colombo et al., 2013). Inhibition of the ESCRT-0 and I proteins Hrs, 
STAM1 and TSG101 results in the reduction of exosome secretion 
(Colombo et al., 2013). The ESCRT-I complex binds and recruits 
ESCRT-II subunits to the endosome membrane, thereby initiating 
inward budding (Andreu & Yanez-Mo, 2014; Colombo et al., 2013). 
Subsequently, ESCRT-II nucleates ESCRT-III complex assembly and 
polymer formation. Finally, The ATPase Vps4 joins the ESCRT-III poly-
mer and induces its disassembly from the membrane facilitating vesicle 
scission to form the ILVs (Wollert et al., 2009). In addition to orches-
trating ILV formation the ESCRT complexes also determine cargo sorting 
into the ILVs (Henne et al., 2011; Minciacchi et al., 2015). 
The findings that depletion of key ESCRT subunits did not result in 
full inhibition of MVB formation and exosome secretion pointed to the 
existence of ESCRT-independent mechanisms of ILV formation (Stuffers 
et al., 2009; Zhang et al., 2019a). It was shown that members of the 
tetraspanin protein family such as CD9, CD63, CD81, and CD82, and 
lipid rafts play pivotal roles (Andreu & Yanez-Mo, 2014; van Niel et al., 
2011). ILV formation of the ESCRT-independent pathway requires the 
production of ceramide by neutral sphingomyelinase 2 (nSMase2) 
(Trajkovic et al., 2008). Ceramide can induce coalescence of lipid-raft 
microdomains of the endosomal membranes that promotes 
domain-induced inward budding giving rise to cargo-loaded ILVs 
(Trajkovic et al., 2008). 
nSMase2 also controls the loading of the ILVs with compounds such 
as RNAs by its downstream factor NSMAF/FAN (neutral sphingomyeli-
nase associated factor) that is involved in the recruitment of RNA 
binding proteins for ILV cargo selection (Leidal et al., 2020). 
Once formed, MVBs can either fuse with lysosomes for lysosomal 
degradation or with the plasma membrane to release their content in the 
form of exosomes into the extracellular space (Piper & Katzmann, 2007). 
Factors that define the fate of MVBs remain to be resolved. Members of 
the Rab family including Rab2b, Rab9a, Rab27a, Rab 27b, Rab35, have 
been shown to be involved in trafficking and docking of MVBs to the 
plasma membrane (for more information on the role of Rab family in 
EVs please see references (Blanc & Vidal, 2018; Eitan et al., 2016). It has 
been suggested that cholesterol enrichment of the MVB membranes 
stimulates fusion of MVBs with the plasma membrane (Doyle & Wang, 
2019; Mobius et al., 2002; Mobius et al., 2003). Posttranslational 
modifications may also determine the fate of MVBs. A recent study by 
Villarroya-Beltri et al. showed that ISGylation of TSG101 stimulates 
lysosomal degradation of MVBs and reduces exosome secretion (Villar-
roya-Beltri et al., 2016). 
The different biogenetic routes also result in different cargo 
composition of exosomes. Some proteins are only found in exosomes 
produced by the ESCRT-dependent pathway while others require the 
ESCRT-independent route for their secretion via exosomes. For example 
loading of ILVs with the epidermal growth factor (EGFR) requires Hrs 
and STAM1 of ESCRT complexes (Bache et al., 2003; Raiborg et al., 
2002; Urbe et al., 2003). This was further confirmed by Stuffers et al 
who showed that depletion of ESCRT components inhibit EGFR sorting 
into ILVs (Stuffers et al., 2009). Inhibition of nSMase2, which is a key 
player in the ESCRT-independent route of ILV formation (see above) 
significantly reduces CD82 mediated exosome release of β-catenin sug-
gesting that β-catenin secretion requires the ESCRT-independent 
pathway (Chairoungdua et al., 2010). Another example was given by 
Theos et al. indicating that the sorting of melanosomal protein Pmel17 
(Pmel17) into ILVs is insensitive to Hrs depletion and therefore Pmel17 
sorting is arranged independently of the ESCRT machinery (Theos et al., 
2006). 
Once released, EVs can target cells in their vicinity as well as 
reaching those located at far distances. In general, there are three stra-
tegies described for EVs targeting and uptake. One strategy is to simply 
fuse with the plasma membrane of the target cells after which the EV’s 
content is released into the cytoplasm. Membrane fusion is thought to be 
mediated by several proteins amongst which are soluble N-ethyl-
maleimide-sensitive factor attachment protein receptors (SNAREs). The 
assembly of the four complementary SNARE motifs mediates a tight 
connection between the two lipid membranes to fuse (Jahn & Scheller, 
2006; Kwok et al., 2021). The other route involves ligand-receptor 
interaction in which EVs dock with membrane exposed ligands to 
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receptors on the plasma membrane of the recipient cells and trigger 
cascades of intracellular signaling events (Fu et al., 2020). In the ma-
jority of cases, however, internalization of EVs by endocytosis seems to 
be the most important route. The underlying mechanisms arranging EV 
endocytosis are not yet clear but several mechanisms have been sug-
gested (for more in depth information the reader is referred to the 
recently published review on EVs transportation and uptake by (Kwok 
et al., 2021). These include clathrin-mediated endocytosis (CME). In this 
model clathrin protein together with other components such as 
clathrin-adaptor proteins and scaffold proteins form clathrin coated 
endocytotic vesicles (Kaksonen & Roux, 2018). It is noteworthy to 
mention here that CME is the major pathway in synaptic vesicle protein 
internalization (Saheki & De Camilli, 2012). Additionallly, CME actively 
participates in synaptic cargo retrieval from the plasma membrane after 
physiological stimuli (Granseth et al., 2006; Nicholson-Fish et al., 2015). 
Other mechanisms include phagocytosis, micropinocytosis, and 
caveolin-dependent endocytosis, a process through which cave-like 
structures known as caveolar vesicles are formed and pinched off from 
the plasma membrane into the cytosol (Kwok et al., 2021). Several 
proteins have been identified to play a role in EV uptake by recipient 
cells. These include lectins, integrins, intracellular adhesion molecules 
(ICAMs), and proteoglycans (Murphy et al., 2019; van Niel et al., 2018; 
Zhang et al., 2019a; Zoller, 2009). Tetraspanins, a family of trans-
membrane proteins, also participate in the interaction between EVs and 
recipient cells. In addition to their roles in ESCRT-independent ILV 
biogenesis and cargo sorting, Tetraspanons also have a role in deter-
mining the recipient cell for exosome uptake (Jankovicova et al., 2020; 
van den Boorn et al., 2013). Notably, the distinct tissue-homing 
behavior of EVs is due to tetraspanin-enriched-microdomains (TEM) in 
which tetraspanins interact with integrins and determine target 
selection (van den Boorn et al., 2013). 
The content loaded into EVs is generally a collection of biomolecules 
obtained from the parental cell. However, there are a few common 
protein markers detectable in almost all EVs/exosomes. These include 
classic exosome markers such as tetraspanin proteins CD9, CD63, and 
CD81,CD82 as well as HSP70, HSP90β, ALIX, TSG101 and Flotillin 
proteins (Doyle & Wang, 2019; Kowal et al., 2016). A large amount of 
studies has been performed to identify and characterize EV content by 
Multi-omics approaches such as next generation sequencing and mass 
spectrometry. The outcome is collected in three online data repositories: 
Vesiclepedia, EVpedia, and ExoCarta (Kalra et al., 2012; Keerthikumar 
et al., 2016; Kim et al., 2013). It is thought that in regards to CNS, 
miRNAs are the standout elements among the other components of EVs 
(Batiz et al., 2016; Luarte et al., 2016b). They are involved in regulating 
synaptic plasticity as well as neuroprotection (Micci et al., 2019; Prop-
erzi et al., 2015). Moreover, each miRNA is able to target and repress the 
translation of as many as hundreds of mRNAs (Enright et al., 2003; Krek 
et al., 2005; Stevanato & Sinden, 2014). 
Numerous studies have investigated the function of EVs particularly 
in neurodegenerative disorders. However, less is known about their 
pathological impact on neurodevelopmental disorders (for a recent re-
view see Gomes et al. 2020) (Gomes et al., 2020). The purpose of the 
present study is to shed light on the role of EVs by presenting a 
comprehensive review of literature on their role during CNS develop-
ment. This review suggests new insights into the potential link of exo-
somes and some of the underlying pathologies in disorders of 
neurodevelopment. 
CNS has the most complex structure in the body consisting of various 
cell types generated in a spatio-temporal manner and each cell type has a 
distinct morphology and function. Describing the CNS structure and 
Fig. 1. Summary of major developmental milestones. Neuroepithelial cells (NECs) inside the neural tube populate the ventricular zone (VZ) through symmetric 
division. Notch signaling, the defining factor in cell fate decision, maintains the balance between proliferation and differentiation. NECs with inactive Notch signaling 
undergo asymmetric division to produce the first neurons, known as short precursor neurons (SNPs), as well as Radial Glial Cells (RGCs). Besides their proliferation, 
RGCs in subventricular zone (SVZ) divide asymmetrically to generate intermediate progenitor cells (IPCs) and neurons. The outer radial glial cells (oRGs) reside in 
the outer subventricular zone (OSVZ) and give rise to the majority of neurons (most notably in human). IPCs divide symmetrically to produce two neurons. Neurons 
migrate away from VZ and SVZ to reach the cortical plate (CP) and cortical marginal zone (MZ) where they eventually become mature neurons. Newborn neurons 
start their migration in the intermediate zone (IZ) by using the long basal radial processes of the RGCs as the scaffold (Cooper, 2014; Hirota & Nakajima, 2017; Tan & 
Shi, 2013). Towards the end of neurogenesis and by receiving signals from neurons, RGCs switch to gliogenesis to produce astrocytes and oligodendrocyte progenitor 
cell (OPC). During synaptogenesis, axons start to interact with nearby dendrites, a process that undergoes maturation to establish and stabilize synapses. The excess in 
synapse formation is eliminated during pruning to remove the weak synapses. Mature oligodendrocytes facilitate the fast transport of signals along neurons by 
wrapping the neuronal axons with myelin sheaths. The approximate timelines provided for each step are from the following references: Neurulation (Muller & 
O’Rahilly, 1987; Muller & Orahilly, 1988), Neurogenesis (Bystron et al., 2008; Rakic, 1988), Gliogenesis (Choi & Lapham, 1978; Jakovcevski et al., 2009), Syn-
aptogenesis and synaptic pruning (Huttenlocher, 1979; Petanjek et al., 2011), and Myelination (Jakovcevski et al., 2009; D. J. Miller et al., 2012). 
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function is well beyond the scope of the present review and therefore we 
only specify and briefly describe the parts highlighted in EVs studies of 
the developing CNS. We start from neurogenesis followed by gliogenesis 
and continue to synaptogenesis, synaptic pruning, and eventually 
myelination. Additionally, since neurogenesis is an ongoing process we 
will also have a look at the role of EVs in adult neurogenesis. Fig. 1 
represents a schematic visualization of the CNS developmental stages. 
2. Embryonic neurogenesis 
CNS development begins by the neurulation process when the neural 
plate folds inwardly to eventually form the neural tube. Shortly after 
being formed, the neural tube undergoes patterning by which three axes 
are derived: anterior-posterior, medial-lateral, and dorsal-ventral 
(Hemmati-Brivanlou & Melton, 1997). Neural tube patterning is regu-
lated by morphogens such as Sonic Hedgehog (SHH), Bone morphoge-
netic proteins (BMPs), Retinoic Acid (RA), Fibroblast Growth Factor 
(FGF), and Wnt that eventually lead to formation of four different re-
gions in CNS: forebrain, midbrain, hindbrain, and spinal cord (Guerout 
et al., 2014; Hemmati-Brivanlou & Melton, 1997). 
Before the initiation of cortical neurogenesis, Neuroepithelial cells 
(NECs) located in the neural tube undergo proliferation (at an expo-
nential rate) through symmetric division. Proliferation occurs in the 
primary proliferative zone, the ventricular zone (VZ), of the neural tube 
(Fietz & Huttner, 2011; Martinez-Cerdeno & Noctor, 2018; Pinto & Gotz, 
2007). Changes in the proliferation mode from symmetric division to 
asymmetric division is the starting point of neurogenesis (Caviness et al., 
2003; Gotz & Huttner, 2005). Asymmetric division produces one NEC 
while the other daughter cell becomes a progenitor cell, also known as 
radial glial cell (RGC). NECs are also capable of directly producing short 
neuronal precursors (SNPs) (Gal et al., 2006; Stancik et al., 2010) which 
are known to be the first population of neurons generated in CNS. Cell 
transition from proliferation to differentiation is influenced by Notch 
signaling that suppresses differentiation and is more in favor of prolif-
eration (Imayoshi et al., 2010; Lutolf et al., 2002). Thus, newly gener-
ated NECs with active Notch signaling are programmed to preserve the 
cell pool by self-renewing divisions while those with inactive Notch 
signaling take a different path towards differentiation. Symmetric and 
asymmetric cell divisions are also present in neuronal progenitor cells 
though at a more restricted manner compared to NECs (Gotz & Huttner, 
2005; Holguera & Desplan, 2018). While symmetric proliferative divi-
sion maintain the neural progenitor cell pool, asymmetric cell division 
either directly produces neurons or generates intermediate neuronal 
progenitor cells, also known as amplifying progenitor cells. They 
migrate radially to the second proliferative zone, known as the sub-
ventricular zone (SVZ) (Noctor et al., 2001; Noctor et al., 2004). 
Intermediate progenitor cells (IPCs) are subjected to symmetric 
neurogenic division to produce two pairs of postmitotic neurons (Mar-
tinez-Cerdeno et al., 2006; Noctor et al., 2004; Tan & Shi, 2013). 
Additionally, there is another subtype of progenitor cell, radial glia-like 
progenitor cells, also known as outer radial glial cells (oRGs). They 
reside in the outer subventricular zone (OSVZ) in human. They are 
morphologically different from RGCs and IPCs (Hansen et al., 2010; X. 
Wang et al., 2011) and able to produce more IPCs through asymmetric 
division (Hansen et al., 2010; LaMonica et al., 2013).The expansion and 
complexity of human neocortex is largely due to the OSVZ and most 
notably due to oRGs. The OSVZ is populated with IPCs and oRGs 
(Hansen et al., 2010). Recent studies revealed that oRGs are also present 
in mice (Shitamukai et al., 2011; X. Wang et al., 2011) though the extent 
to which they contribute to cortical expansion is restricted. In mice, IPC 
proliferation does not exceed more than one or two cell cycles while in 
higher mammals such as primates, the IPCs represent higher 
self-renewing capacity and thus increase the cortical size and complexity 
(Hansen et al., 2010) (X. Wang et al., 2011) (Martinez-Martinez et al., 
2016) (Tiberi et al., 2012). 
Neuronal migration to the cortical plate, which ends the neocortex 
development, is a gradual process. Post-mitotic neurons produced in VZ 
and SVZ migrate through the intermediate zone to eventually reach the 
top of the cortical plate, where they further differentiate and turn into 
their distinct phenotype. 
3. Gliogenesis 
Generation of neurons and generation of glial cells take place in a 
sequential order such that neurons are the first to be generated followed 
by astrocytes and, later on during the postnatal period, oligodendrocyte 
precursor cells and oligodendrocytes (Adnani et al., 2018; J. Liu & 
Casaccia, 2010). Transition to gliogenesis occurs towards the end of 
neurogenesis when RGCs receive signals from newly formed neurons, 
which trigger their gliogenic fate to take action. The intrinsic and 
extrinsic factors are the key players in switching from neurogenesis to 
gliogenesis (Adnani et al., 2018; F. D. Miller & Gauthier, 2007; Zar-
ei-Kheirabadi et al., 2020). For instance, cytokines produced by newly 
generated neurons in the cortical plate are demonstrated to promote 
gliogenesis through a negative feedback mechanism (Barnabe-Heider 
et al., 2005). Newly generated cortical neurons secrete cardiotrophin-1 
(CT-1) which acts as an extrinsic gliogenic signal to trigger the con-
version from neurogenesis to gliogenesis. Thus, CT-1 instructs multi-
potent cortical precursor cells to produce astrocytes. 
All the aforementioned studies clearly indicate that RGCs are the 
common precursor cell pool that create heterogeneity in the CNS by 
generating different cohorts of cell types at different time points and 
places. This pluripotent property of RGCs therefore makes them a good 
candidate in cell-based therapy for diseases with neurological 
phenotypes. 
EVs during neurogenesis and gliogenesis 
A large number of studies have focused on the potential therapeutic 
effect of the neural stem cell secretome in neurological disorders. Neural 
stem/progenitor cells secrete EVs that are instrumental in intercellular 
communication. In spite of their small size, their content covers a wide 
variety of biomolecules such as small fragments of DNA, proteins, 
mRNAs, miRNAs as well as metabolites and lipids. The content of EVs is 
determined by the parental cell and although its quantity is considered 
low, its efficacy to induce changes in the recipient cell is inevitable. The 
study by Stevanato et al. demonstrated that the exosomal miRNA 
released by human neural stem cells (hNSCs) reflects the miRNA content 
of the producing cells. Furthermore, the exosomal miRNA can be 
transferred functionally to recipient cells (Stevanato et al., 2016). They 
first performed next generation sequencing on cellular and exosomal 
content of hNSCs that revealed a differentially enriched subset of miR-
NAs in exosomes including Hsa-miR-1246, hsa-miR-4488, 
hsa-miR-4508, hsa-miR-4492 and hsa-miR-4516. Stoichiometry findings 
by real time PCR on highly enriched Hsa-miR-1246 indicated that there 
were at least 10 copies of this miRNA per exosomes. Moreover, func-
tional analysis by 3’ untranslated region dual luciferase reporter assay 
indicated the reduction in luciferase activity in Hela cells, used as target 
cells, indicating that the amount of transferred miRNA is sufficient to 
elicit changes in recipient cells. 
EVs efficacy is also determined by their dosage. In a study by Stornati 
et al, EVs extracted from embryonic mouse neural progenitor cells 
(NPCs) from spinal cord were shown to differentiate recipient NPCs to 
astrocytes (Stronati et al., 2019). To assess the dosage efficacy, NPCs 
were exposed to two different concentration of EVs. Results indicated 
that cells treated with higher concentration of EVs had a higher per-
centage of Glial Fibrillary Acidic Protein (GFAP)-positive astrocytes. 
EVs can directly participate in neurogenesis. Stornati et al. demon-
strated that NPCs derived from embryonic mouse spinal cord can pro-
duce and release exosomes both at the proliferation and differentiation 
phases (Stronati et al., 2019). Cultured in expansion medium, NPCs 
released exosomes which were confirmed by the presence of exosomal 
markers TSG-101 and tetraspanin markers CD63 and CD81. Further-
more, when stimulated by differentiation mediums containing either 
N. Bahram Sangani et al.                                                                                                                                                                                                                     
Progress in Neurobiology 205 (2021) 102124
5
Fetal Bovine Serum (FBS) or BMP, NPCs showed a highly enriched 
astrocytic phenotype with less preference for neuronal phenotype. 
Similarly, the extracted EVs, from both differentiated astrocytes and 
neuronal cells, also stimulate the proliferating NPCs more towards the 
astrocytic lineage. This study indeed indicates the important role of EVs 
in transition of NPCs from a neurogenic to a gliogenic lineage. 
Neurogenesis is an ongoing process that continues into adulthood 
though at considerably lower rates resulting in the creation and main-
tenance of only a small size pool of NPCs. The paucity of NPCs in 
adulthood is a major obstacle for therapeutic strategies employing NPCs 
or NPC-derived EVs. Re-programming of somatic cells into NPCs has 
provided a new opportunity. Using transcription factors Brn2, Sox2, and 
Foxg1 Ma et al. reprogrammed mouse fibroblast and astrocytes into 
induced NPCs (iNPCs) (Ma et al., 2019b). Interestingly, they demon-
strated that iNPCs were able to release EVs at higher levels when 
compared to wild type (WT)-NPCs as determined by Nanoparticle 
Tracking Analysis and Western Blotting of EV markers Flotillin-1, Flo-
tillin-2 and HSP70. In addition, iNPC-EVs promoted proliferation of 
WT-NPCs significantly stronger as compared to EVs fromWT-NPC. Pro-
teomics analysis revealed that, in fact, the expression levels of growth 
factor related domains such as growth factor receptor cysteine rich 
domain, EGF-like domain, and EGF-like calcium-binding domain are 
higher both in iNPC and in their EVs. Further analysis by perturbation of 
function assay suggested that the aforementioned growth factors in-
crease the proliferation rate in NPCs through their downstream MER-
K/ERK pathways. In a follow up study, it was demonstrated that 
NPC-originated exosomes (EXO) can induce the differentiation of 
cortical NPCs into neuronal cells in differentiation medium whereas 
iNPC-derived exosomes (iEXO) appeared to possess a much lower po-
tency to differentiate cortical NPCs into neuronal cells (Ma et al., 
2019a). Neither exosomes population induced significant differentiation 
towards glial differentiation. Microarray analysis revealed that EXOs 
carry miRNA-21a at a much higher level than iEXOs. Using a 
miRNA-21a mimic and a miRNA-21a inhibitor it was demonstrated that 
the mimic suppressed the proportion of GFAP+ glial cells and increased 
the proportion of tuj1+ neuronal cells, whereas the inhibitor caused the 
opposite effect. Collectively, these results highlight the role of 
miRNA-21a in determining the NPC cell fate more towards neurogenesis 
rather than gliogenesis. This is in contrast with the results obtained by 
Stornati et al. (Stronati et al., 2019). Possible explanations are: Firstly, 
Stornati et al. collected NPCs from mouse spinal cord while the NPCs in 
the Ma et al.study were derived from cortex. Both collected NPCs at day 
13.5 of mouse embryonic development. Secondly, Stornati et al. inves-
tigated the differentiation of NPCs in FBS and BMP4 differentiation 
medium. 
Cell-to-cell communication is a vital part of CNS structure, function, 
and homeostasis both during development and afterwards in adulthood. 
Besides electrical and chemical signals, exosome-based cell-cell inter-
action is also important not only between neurons but also in neuro-glial 
interactions. A wide range of examples is provided throughout this re-
view. For instance, Morton and colleagues identified a bidirectional 
interaction between NCSs and microglia, which is mediated by EVs 
(Morton et al., 2018). They first revealed that murine neonatal sub-
ventricular NSCs release EVs. This was confirmed by detecting the EVs 
markers CD63 and CD9 as well as the exosome cargo protein ALIX. The 
destiny of released EVs was also determined by tracking CD9-GFP pos-
itive particles. The reduction of these particles over the time overlapped 
with influx of microglia suggesting an active clearance of EVs by 
microglia. They reported that microglia-iba1 positive cells are 
co-localized with CD9-GFP positive particles released from electro-
porated SVZ. For further assessment, NSC-derived EVs of SVZ were 
labeled with the lipophilic dye DiI and transplanted to P0 murine pups. 
The labeled EVs were detected in microglia-iba1 positive cells as well as 
cells that were double positive for CD68 and CD11b (neonatal sub-
ventricular zone markers). These results confirmed that SVZ 
NSC-derived EVs target microglia. Further analysis revealed that these 
EVs were enriched with miRNAs including miR-9, Let-7, and miR-26, 
which belong to miRNA families with a role in regulating microglia 
morphology and physiology (Kumar et al., 2015; Lehmann et al., 2012; 
Yao et al., 2014; L. Zhang et al., 2015). Transfecting exosomes with 
synthetic Let-7 miRNA enabeled them to change microglia morphology 
and induced cytokine release that suppressed proliferation of SVZ NSCs. 
It was proposed that NSCs and microglia establish an intricate 
communication network based on EV release that regulates SVZ NSC 
proliferation. NPC-derived EVs are also instrumental in conveying 
functional immune responses. The study by Cossetti et al. revealed that 
the content of NPC-derived EVs mirrors the activation status of the 
parental cell (Cossetti et al., 2014). Treatment of murine SVZ NPCs with 
proinflammatory cytokines caused selective sorting of components of 
the interferon-gamma (IFN-ү) pathway into the EVs. Amongst these 
components was the interferon gamma receptor 1 (Ifngr1), which was 
expressed at the EV’s surface. These EVs triggered IFN-ү-dependent stat1 
signaling in NIH 3T3 cells. Advanced-imaging techniques demonstrated 
a rapid adhesion and incorporation of these EVs in the target cells. As 
opposed to their fast incorporation, their degradation was shown to be 
rather slow due to the lack of lysosomal-associated membrane protein 1 
(LAMP1) suggesting a sustained and robust impact of these EVs on the 
recipient cell. Together these experiments illustrate the role of 
NPC-derived EVs in immune responses and that this role is modulated by 
the microenvironment of the EV-producing NPC. 
In addition to being conveyors of immune responses, EVs can also 
provide protection against inflammation. It was previously reported that 
NPCs in concert with endothelial progenitor cells are able to reduce 
hypoxia-induced ROS overproduction in brain endothelial cells (ECs) 
(Wang et al., 2016). The study by Liu and colleagues investigated the 
underlying mechanism through which NPCs provide protection against 
oxidative stress in brain ECs and highlighted the role of NPC-derived 
exosomes (NPC-EXs) (H. Liu et al., 2017). They demonstrated that 
miR-210 in NPC-EXs mediates the antioxidant effect on ECs by using 
miR-210 mimic, miR-210 inhibitor and scramble control miRNA. 
NPC-EXs carrying miR-210 reduced Nox2 levels and apoptosis of ECs 
exposed to the oxidative stress inducer angiotensin II (Ang-II). In addi-
tion, NPC-EXs carrying miRNA-210 diminished Ang-II induced upregu-
lation of ephrin A3 and prevented Ang-II induced loss of ECs ability of 
tube formation through normalization of the 
phosphorylated-VEGFR2/VEGFR2 ratio. 
It is worth mentioning here that the EV-mediated crosstalk between 
neural and brain endothelial cells covers a wider array of processes. For 
instance, neuron-derived exosomes target endothelial cells to regulate 
the brain vascular integrity (Xu et al., 2017). These exosomes harbor a 
neuron-enriched miR-132 that upregulates vascular endothelial cad-
herin protein, also known as Cadherin 5 (Cdh5), by directly targeting 
eukaryotic elongation factor 2 kinase (eef2k) in endothelial cells. 
Dysfunction of miR-132 reduces Cdh5 expression (and its partner 
β-catenin) and is associated with severe intracranial hemorrhage and 
dysregulation of brain vascular integrity in zebra fish larvae. 
EVs seem to have a dynamic interaction with their microenviron-
ment. Not only is their composition determined by the microenviron-
ment (Cossetti et al., 2014), they can also condition the 
microenvironment. The study by Iraci et al. demonstrated that 
NPC-derived EVs carry metabolic enzymes and act as independent 
metabolic units capable of influencing the composition of their micro-
environment (Iraci et al., 2017). Metabolic and functional analyses 
showed that NPC-derived EVs carry functional Asparaginase-like protein 
1 (Asrgl1) that converts Aspargine (Asn) into Aspartate (Asp), which is 
released into the microenvironment. 
4. Neurogenesis to be continued (Adult Neurogenesis) 
The exciting discovery in 1960’s, which revealed that neurogenesis 
persists to adulthood, revolutionized the dogma around embryonic-born 
neurons as the solo inhabitants of CNS. Neurogenesis in adulthood takes 
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place at a limited rate and restricted to only two main regions in the 
brain also known as neurogenic niches. The subgranular zone of the 
dentate gyrus in hippocampus (Eriksson et al., 1998) and the sub-
ventricular zone in the lateral ventricular wall of the cerebral cortex 
(Johansson et al., 1999). The NPCs in dentate gyrus represent similar 
features to radial glial cells and are therefore referred as RG-like cells 
(Martinez-Cerdeno & Noctor, 2018), their function is shown to be 
important in cognitive activity of hippocampus such as pattern separa-
tion (Aimone et al., 2011), spatial learning and memory (Dupret et al., 
2008). The newly produced neurons in the adult SVZ migrate to olfac-
tory bulb and are differentiated to interneurons (Lim & Alvarez-Buylla, 
2016). Self-renewal and multipotency of neural stem /progenitor cells of 
embryonic origin, and to some extent adulthood NSC, have made them 
potential candidates for therapeutic purposes. 
In regenerative medicine, neural stem cell transplantation has found 
its place as a relatively promising treatment. There has been a vast 
growth in clinical indications for such therapeutic approach including 
Parkinson disease, Huntington disease, Alzheimer disease, Amyotrophic 
lateral sclerosis, spinal cord injury and stroke (Takagi, 2016; Tang et al., 
2017). However, there are still many challenges to be addressed. The 
ethical issues towards NSC transplantation are nowadays rather paved 
by reprogramming of somatic cells into induced pluripotent stem cells 
(iPSCs). Nevertheless, one should keep in mind the adverse outcome 
events associated with using such cell lines including the risk of 
tumorigenesis and immune response (Li et al., 2008; Nam et al., 2015). 
In addition, the administered stem cells need to migrate to the target site 
and differentiate into the desired neuronal cell type. They should also be 
able to integrate with the neural circuit and form proper synaptic con-
nectivity with the host cells in order to exert their therapeutic effect 
(Marsh & Blurton-Jones, 2017). Moreover, vascular obstruction is 
another challenge on the way of achieving desired efficacy from NSC 
grafting (Luarte et al., 2016b; Xin et al., 2014). Recently, EVs have 
become more and more appreciated as therapeutic alternative to the 
cell-based therapy. Increasing lines of evidence support their thera-
peutic functionality in the brain in vivo (Spellicy & Stice, 2020; Zhang 
et al., 2019b) In addition, due to their size, blood-brain barrier (BBB) is 
actually not a barrier on their way to target brain cells (Saeedi et al., 
2019). 
EVs in adult neurogenesis 
In addition to NPCs, adult neurogenic niches also host a variety of 
other cell types such as astrocytes, microglia, neuroblasts, endothelial 
cells, pericytes as well as mature and immature neurons (Batiz et al., 
2016; Luarte et al., 2017). Proper communication between these cellular 
components is vital both for neurogenesis and for the integration of 
adult newborn neurons with synaptic circuitry in the hippocampus 
(Carlen et al., 2002; J. T. Goncalves et al., 2016). A combination of 
extrinsic factors including morphogens, growth factors, and neuro-
transmitters together with intrinsic signals such as transcription factors 
and epigenetic regulators guide neurogenesis through its multiple 
stages. Although the role of EVs in adult neurogenesis has yet to be 
firmly established, there are several lines of evidence supporting their 
involvement. Their potential participation in adult neurogenesis has 
been reviewed by multiple studies (Batiz et al., 2016; Luarte et al., 
2016a; Luarte et al., 2017). For instance, miR-34a, which has a profound 
role in adult neurogenesis and differentiation of developing neurons, has 
also been detected in exosomes released in the medium of neuronal 
cultures (Mollinari et al., 2015). In addition, as mentioned by Bátiz et al, 
some of the protein modulators of adult neurogenesis are also found in 
exosomes though from different cell types (Batiz et al., 2016). Among 
them are Transforming Growth Factor-beta 1 (TGFB1) (C. S. Hong et al., 
2014; Raimondo et al., 2015; Sole et al., 2015; Szajnik et al., 2013; 
Torreggiani et al., 2014), Ephrin-B2 (Mathivanan et al., 2010), Vascular 
Endothelial Growth Factor (VEGF) (Ekstrom et al., 2014; Thompson 
et al., 2013; Torreggiani et al., 2014) as well as proteins that are 
involved in cell fate decision in neurogenic niches such as Pigment 
Endothelium-Derived Factor (PEDF) (Ramirez-Castillejo et al., 2006) 
(Hajrasouliha et al., 2013), Insulin-like Growth Factor Binding Protein 6 
(IGFBP6) (Barkho et al., 2006), Epidermal Growth Factor Receptor 
(EGFR) (Graner et al., 2009), and Fibroblast Growth Factor 2 (FGF2) 
(Hajrasouliha et al., 2013). The same is also reported for some of the 
proteins of signaling pathways such as Wnt, Notch, and SHH signaling 
pathways (Batiz et al., 2016; Wendler et al., 2013). 
Further studies are needed to investigate their direct role in adult 
neurogenesis for two important reasons. Firstly, EVs can negatively 
affect adult neurogenesis. The injection of blood exosomes collected 
from major depressive disorder patients into mice is shown to cause 
depressive-like behavior (Wei et al., 2020). Data from miRNA 
sequencing revealed higher levels of hsa-miR-139-5p in blood exosomes 
which is a negative regulator of neurogenesis and leads to dysfunction of 
adult hippocampal neurogenesis (Wei et al., 2020). Secondly, EVs can 
have therapeutic potential and can improve neurogenesis. Systematic 
administration of exosomes loaded with miR-124 can promote neuro-
genesis after ischemia injury (Yang et al., 2017). 
It has been suggested that re-activating some of the developmental 
signalling pathways in the adult might be beneficial to ameliorate the 
brain injuries (Goncalves et al., 2018). For instance, retinoic acid (RA), 
as a guidance molecule, is crucial for axon/neurite outgrowth during 
development (Dmetrichuk et al., 2006). The RA signaling pathway has 
been shown to regulate remyelination and axonal/neurite outgrowth 
after spinal cord injury (Goncalves et al., 2019;Goncalves et al., 2018). 
Interestingly, exosomes were shown as the important intercellular 
transporter of RA that enable crosstalk between oligodendrocyte pre-
cursor cells (NG2+ cells) and neurons to mediate remyelination and 
axonal/neurite outgrowth. The importance of EVs in mediating the 
neuron-glia crosstalk was further highlighted by Fruhbeis et al. The 
authors demonstrated that the small extracellular vesicles released by 
oligodendrocytes are vital for axonal maintenance and support axonal 
fast transport. This study suggested that since oligodendroglial exo-
somes are critical for neuronal integrity, they could be a causative link 
between glial dysfunction and axonal degeneration (Fruhbeis et al., 
2020). 
5. Synaptogenesis 
Once neuronal migration is accomplished, neurons undergo 
morphological changes, also known as neuromorphogenesis, to appre-
ciate synaptic connectivity (Cornell & Toyo-Oka, 2017). These changes 
include the growth of axonal and dendritic cones, which eventually give 
rise to formation of pre-synaptic terminal and post-synaptic sites. Axons 
elongate to reach the appropriate post-synaptic targets to form synapses 
and facilitate neurotransmission. The choice of postsynaptic site is 
different in glutamatergic and GABAergic neurons. Glutamatergic syn-
apses are formed on dendritic spines while GABAergic synapses take 
place on somas and proximal dendrites (Sanes et al., 2019). Synapto-
genesis is a long-term developmental process that initiates in the 
developing brain at around the week 28 of gestation and continues to the 
postnatal period (Huttenlocher, 1990). Synaptic density increases 
exponentially during infancy and reaches its peak, which is 50% higher 
than in adult, at around 1-2 years. This trend begins to decline between 
ages 2 - 16 years (Huttenlocher, 1979) by synaptic pruning. 
EVs during synaptogenesis 
As with the other stages of CNS development, synaptic differentia-
tion and maturation processes are regulated by a distinct set of proteins 
and miRNAs. Interestingly, there is evidence that synaptic components 
are incorporated into EVs, supporting their role at synapses. Results 
obtained by electron microscopy revealed that somato-dendritic com-
partments of differentiated cortical and hippocampal neurons can 
release exosomes in vitro (Lachenal et al., 2011). Furthermore, the 
exosome release was shown to be modulated by glutamatergic synaptic 
activity and calcium influx. It was first demonstrated that mature rat 
cortical and hippocampal neurons secrete exosomes. Using two different 
concentration of KCl, exosome release was shown to be mediated by 
N. Bahram Sangani et al.                                                                                                                                                                                                                     
Progress in Neurobiology 205 (2021) 102124
7
KCl-induced depolarization since antibodies against exosomal markers 
Flotillin-1 and ALIX showed stronger immunoreactivity in the cell cul-
ture medium treated with the high KCl concentration. Therefore, exo-
some release from mature neurons is closely associated with 
depolarization. In addition, incubation with the calcium ionophore 
ionomycin, which causes a rise in cytosolic calcium, increased exosome 
release. Furthermore, antagonists of GABA receptor significantly 
increased release of exosomes, due to enhancement of glutamatergic 
spontaneous activity. This was further confirmed with antagonists of 
NMDA and APMA receptors. These antagonists both inhibited the in-
crease in exosome release confirming that glutamatergic synaptic ac-
tivity modulates the exosome release from mature neurons. In addition, 
exosomes were found to contain GluR2/3 subunits of AMPA receptors, 
which led the authors to suggest that exosomal release of AMPA re-
ceptors, which is followed by glutamatergic synaptic activity, is a 
mechanism to eliminate synaptic receptors as a response to alterations of 
synaptic plasticity. 
The presence of AMPA receptor subunit GluR2/3 was previously 
reported in exosomes derived from primary cultures of rat cortical 
neurons. Fauré et al. demonstrated that rat primary cortical neurons are 
able to secrete exosomes (Faure et al., 2006). Characterization of their 
content by immunoblotting revealed that they carry GPI anchored prion 
protein and neuronal cell adhesion molecule L1 as well as AMPA re-
ceptor subunit GluR2/3. Authors suggested that exosomes might act as a 
disposal mechanism in synapses -where lysosomes are not present- to 
discard AMPA receptors in events such as synaptic depression. However, 
these exosomes were shown to lack NMDA receptor subunit NR1 indi-
cating that such disposal strategy is not relevant to the other glutamate 
receptors. It was also demonstrated that exosomal release by primary 
cortical neurons can be regulated by depolarization and that GluR2 
secretion upon depolarization is associated with exosomes. In a review 
by Smalheiser, multiple scenarios were discussed about the role of 
exosomes derived from postsynaptic membranes in transferring synaptic 
proteins e.g. calmodulin-dependent protein kinase II (CAM kinase II) 
alpha and mRNAs and miRNAs to presynaptic terminals, an action that 
highlights their involvement in synaptic plasticity (Smalheiser, 2007). In 
particular, it was proposed that exosomal loading and intracellular 
transport of synaptic signaling molecules occur at the postsynaptic lipid 
rafts. 
In addition to transfer of synaptic related proteins, EVs are confirmed 
to carry miRNAs with functionalities at synapses. The study by Morel 
et al. indicated a role for exosomes in modulating synaptic activity 
through astrocyte-neuronal communication (Morel et al., 2013). In their 
study, miR-124a was highlighted as the key component carried by 
exosomes from neurons to astrocytes where it targets Glutamate Syn-
thase NADH (GLT1). GLT1 is a rodent analog of human excitatory amino 
acid transporter 2 (EAAT2), an astroglial synaptic protein with a key role 
in glutamate uptake and clearance at synapses (Kim et al., 2011). It was 
demonstrated that GLT1 physiological function depends on the signals 
received by neurons. Protein and mRNA levels of GLT1/EAAT2 in as-
trocytes were significantly increased when co-cultured with neurons 
(Gegelashvili et al., 1997; Schlag et al., 1998). Moreover, due to having 
long 3´untranslated region (UTR), authors proposed that GLT/EAAT2 
could be a target for miRNA-mediated regulations. It was first demon-
strated that primary cultures from mouse cerebral cortex neurons and 
astrocytes secrete exosomes. Interestingly, miR-124a was highly 
enriched in neurons and their harvested exosomes while cultured as-
trocytes presented only a minimum amount of miR-124a. Neuronal 
exosomes were then shown to be internalized in astrocytes as detected 
by time-lapse imaging of the fluorescently labeled exosome membranes. 
Furthermore, these exosomes were able to increase GLT1 protein levels 
in cultured astrocytes. Direct transfection of astrocytes with miR-124a 
increased GLT1 protein expression without any change on mRNA level 
indicating that miR-124a regulatory effect is at the translational level. In 
vivo experiments in which a specific antisense miR-124a was injected 
into the striatum part of the mouse brain resulted in reduction of GLT1 
and glutamate uptake. Moreover, it was indicated that miR-124a regu-
latory effect on GLT1 is independent of ligand ephrin3, a putative sup-
pressor of GLT1, confirming that miR-124a association with GLT1 
expression is indirect. Moreover, exogenous delivery of miR-124a into 
the SOD1 mouse model of amyotrophic lateral sclerosis efficiently 
reduced pathological loss of GLT1 in this model. Collectively, these re-
sults underscore the importance of EVs in regulating synaptic function 
by targeting astrocytes that act alongside of neurons to ensure normal 
synaptic function. 
A recent study by Sharma et al. highlighted the potential role of EVs 
in improving neurogenesis, synaptogenesis, and circuit assembly in Rett 
syndrome (Sharma et al., 2019). Rett syndrome is a neurodevelopmental 
disorder and is caused by mutations in the methyl-CpG-binding protein 
2 (MECP2) gene (Amir et al., 1999). MECP2 gene expression is corre-
lated with neuronal maturation and synaptogenesis (Fukuda et al., 
2005; Shahbazian et al., 2002). Proteomics analysis conducted by 
Sharma et al. demonstrated that exosomes from hiPSC-derived neural 
cultures contribute to neural circuit development owing to the signaling 
proteins they carry. Authors showed that these proteins are absent from 
exosomes collected from MECP2 loss-of-function (MECP2LOF) cultures. 
Furthermore, treatment with control exosomes were effective, both in 
vitro and in vivo, in improving neurogenesis. Exosome treatment also 
improved synaptogenesis and circuit connectivity in MECP2LOF cul-
tures. Based on the results, authors suggested that MECP2 mutation 
results in the alteration of protein cargos and signaling bioactivity of 
exosomes. 
EVs are also involved in synaptic growth and function. For instance, 
exosomes are shown to mediate communication between pre-and post-
synaptic cells by transferring a retrograde signaling component, Syn-
aptotagmin 4 (Syt4), which is essential during development and for 
maintenance of synaptic plasticity and growth (Korkut et al., 2013). It 
was demonstrated that presynaptic neurons at neuromuscular junctions 
in Drosophila release Syt4 via exosomes. Syt4 is received by post-
synaptic muscles and regulate the activity-dependent synaptic growth 
and potentiation of spontaneous release. In fact, exosomes coordinate 
the presynaptic function with postsynaptic output by means of Syt4 
transfer. The EVs involvement in synaptic plasticity goes beyond 
transferring retrograde signaling. They also transfer the neuronal Arc 
mRNA. Arc protein activity is vital for long-term memory and consoli-
dation of information as well as synapse eliminaton (Pastuzyn et al., 
2018) and it has been implicated in several neurodevelopmental disor-
ders such as Angelman syndrome (Greer et al., 2010; Pastuzyn & 
Shepherd, 2017), Fragile X syndrome (Park et al., 2008), and Schizo-
phrenia (Fromer et al., 2014; Manago et al., 2016; Purcell et al., 2014). It 
has been demonstraed that Arc EVs can transfer highly abundant Arc 
mRNAs to dendrites e.g. in response to neuronal activity (Pastuzyn et al., 
2018). Similarly, the Arc homolog in Drosophila, dArc1, uses EVs for its 
own mRNA transfer at neuromuscular junctions (Ashley et al., 2018). 
6. Synaptic pruning 
The excess in synaptic contacts created during early infancy will be 
eliminated in a process called synaptic pruning. Sculpting the synapses is 
crucial for proper neural circuit formation and plasticity. It is estimated 
that nearly half of the synapses and neurons will be removed by pruning 
and apoptosis (Jiang & Nardelli, 2016; Stiles & Jernigan, 2010). 
Microglia are the core players in this refinement process (Kettenmann 
et al., 2013; Schafer et al., 2012). Having close association with pre-
synaptic and synaptic elements, microglia are thought to target weak 
synapses for phagocytosis (S. Hong et al., 2016; Schafer et al., 2012; 
Tremblay et al., 2010). Dysfunction of reciprocal interaction between 
microglia and neurons are observed in neurodevelopmental and 
neuropsychiatric disorders (Zhan et al., 2014). 
EVs role in synaptic pruning 
EVs are shown to act as endogenous factors able to eliminate syn-
apses. Lee and collogues revealed an interplay between Wnt and Proline- 
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Rich 7 (PRR7) via exosomes that results in regulating the number of 
excitatory synapses (Lee et al., 2018). Wnt signaling is considered as one 
of the vital synaptogenic factors during both synapse formation and 
maintenance (Dickins & Salinas, 2013). PPR7 was first identified by 
proteomic analysis in postsynaptic density fraction of rat forebrain. 
Although its function was not clear at the time, the interaction with 
NMDA receptor and Postsynaptic Density Protein 95 (PSD-95) suggests a 
role for PRR7 in regulating neural activities (Murata et al., 2005). The 
reciprocal interaction between PPR7 and Wnt reported by Lee et al. 
unraveled a role for PRR7 at synapses. Both PPR7 and Wnt were shown 
to be released in exosomes by rat hippocampal neurons. The opposite 
functions of Wnt and PRR7 maintain the balance between synapto-
genesis and synapse removal and interestingly this action is facilitated 
by exosomes as signal carriers. Authors provided a set of molecular 
mechanisms through which exosomal PRR7 eliminate synapses. These 
include inhibiting exosomal secretion of Wnt, protein degradation of 
PSD-95, and activation of GSK3β as the downstream component of Wnt 
signaling. First, it was shown that PRR7, Wnt5a, and Wnt7a are highly 
enriched in exosomes derived from mouse hippocampal neurons. 
Furthermore, using NMDA receptor antagonist, exosomal release of 
PRR7 was shown to be reduced while AMPA receptor antagonist did not 
achieve the same result indicating that neurons release PRR7 in a 
NMDAR-dependent manner. One of the mechanisms for synaptic elim-
ination is Ubiquitin–Proteasome System (UPS), a strategy that is also 
applied by PRR7 to reduce synaptic scaffolding proteins including 
PSD-95, Membrane Associated Guanylate Kinases (MAGUKs), and 
SAP90/PSD-95-associated proteins (SAPAPs). In addition, PRR7 over-
expression increased the total number of poly-ubiquinated proteins 
confirmed by antibodies against K48-specific poly-ubiquitination. 
Interestingly, PRR7-contaning exosomes were shown to target excit-
atory synapses for removal. This was evident when incubation of naïve 
neurons with these exosomes for 24 h resulted in reduction of excitatory 
synapse numbers, determined by PSD-95 co-localization with vesicular 
Glutamate Transporter 1 (vGLUT1), with no alterations in the number of 
inhibitory synapses. 
Interestingly, there has been recently a role identified for exosomes 
as a regulator of synaptic pruning through their phagocytic ability. 
Culturing rat pheochromocytoma PC12 cells in a serum-free medium 
containing Nerve Growth Factor (NGF), Bahrini and colleagues were 
able to induce the formation of neurite outgrowth and synaptic-like 
structures (Bahrini et al., 2015). Authors also sought to assess the role 
of microglia in the clearance of degenerating neurites. It was observed 
that neurites become degenerated within two days in the absence of 
NGF, however in DMEM containing 10% FBS the degeneration rate was 
lower with most of the neurites still reserved. Intriguingly, when PC12 
cells were co-cultured with MG6, a microglial cell line derived from 
mouse, in DMEM/F10 lacking NGF, neurite elimination rate remarkably 
increased indicating the promotion of pruning by microglia. Considering 
the previous findings that depolarized neurons secrete exosomes (Faure 
et al., 2006) and that neuronal derived exosomes target microglia 
(Cossetti et al., 2012), Bahrini et al. also investigated the association 
between PC12 cells-derived exosomes and microglial function. PC12 
cells were pre-incubated with MG6 cells for 16 h. Comparison of syn-
aptic pruning in pre-incubated MG16 with control MG6 revealed 
stronger ability for pre-incubated MG6 cells in neurite pruning and it 
was therefore proposed that exosomes enhance microglia pruning ac-
tivity. Microarray analysis identified 183 differentially expressed genes 
in pre-incubated MG6 cells with “Phagosome’’ and “Complement and 
coagulation cascades’’ being among the enriched terms. Further quan-
tative PCR analysis indicated the up-regulation of complement factor B 
(Cfb) and complement component 3 (C3) genes. Since C3 mRNA level 
remained unchanged, authors suggested that exosome regulatory effect 
on C3 is at the transcriptional level as opposed to directly transferring 
the mRNA. Thus, exosomes derived from PC12 cells can be engulfed by 
microglia where they enhance phagocytosis by upregulating the 
expression of complement factors. However, the factors in exosomes 
that induce such changes in microglia have yet to be identified. 
7. Myelination 
Fast transport of action potentials is only possible when axons are 
enwrapped by myelin sheaths. Myelination is a long-lasting event 
starting early during postnatal period and extending into adulthood 
(Semple et al., 2013). Oligodendrocytes and Schwann cells organize 
myelination in central and peripheral nervous systems respectively. 
Oligodendrocyte Progenitor Cells (OPC) are produced by NECs in ven-
tricular zones (Bergles & Richardson, 2015; Jiang & Nardelli, 2016). 
After migration throughout the CNS, OPC will be distributed in gray and 
white matters where they undergo differentiation to become 
pre-oligodendrocytes and eventually mature myelinating oligodendro-
cytes (Bergles & Richardson, 2015; Jiang & Nardelli, 2016). Once 
differentiated, they extend their plasma membrane towards axons and 
wrap them with multilayered myelin sheaths. There is also an increase in 
the gene expression of myelin related genes such as Myelin Basic Protein 
(MBP), myelin Proteolipid Protein (PLP), Myelin-Associated Glycopro-
tein (MAG), and Myelin Oligodendrocyte Glycoprotein (MOG) (Bercury 
& Macklin, 2015; van Tilborg et al., 2018) in OPC prior to differentia-
tion. It is obvious that neuron-oligodendrocyte reciprocal interaction 
and the exchanged biomolecules between them are the key factors for 
the myelination process. 
EVs role in Myelination 
Accumulating evidence points to the involvement of EVs in orches-
trating myelination in CNS. We only briefly discuss the evidence in this 
section and refer the reader to a recent excellent review on this topic by 
S. Domingues et al. (Domingues et al., 2020). 
Exosomes secreted by oligodendrocytes are carriers of proteins that 
have been recognized to play a role in myelination. The study by 
Kramer-Albers et al. revealed that exosomes secreted by oligodendro-
cytes contain several myelin proteins including PLP, 2’3’ -Cyclic- 
Nucleotide-Phosphodiesterase (CNP), MBP, and MOG (Kramer-Albers 
et al., 2007). Moreover, it was demonstrated that exosome secretion and 
heterogeneity of secreted exosomes are regulated by intracellular Ca2+
levels suggesting that exosome release by oligodendrocytes is coupled to 
neuronal activity. Besides myelin proteins, the authors also identified 
numerous other proteins including chaperones and enzymes with pro-
posed functions in the relief of cell stress. Thus, they suggested that 
oligodendrocyte-derived exosomes also provide trophic support to the 
axons. Further characterization of oligodendroglial exosomes revealed 
the presence of the classic myelin lipids galactocerebroside and sulfatide 
indicating that oligodendroglial exosomes are uniquely equipped to 
support myelination of axons. 
As mentioned, there is a bidirectional interaction between oligo-
dendrocytes and neurons and EVs are one of the mediators. We noticed a 
feedback principle mentioned by most of the papers. Exosomes are 
secreted from oligodendrocytes under the influence received by neurons 
to arrange a set of alterations in neurons. For instance, in their study 
Fruhbeis et al. demonstrated that neuronal electrical activity (depolar-
ization) triggers glutamate release, which induces Ca2+ influx into oli-
godendrocytes through AMPA and NMDA receptors and subsequently 
stimulates exosome release (Fruhbeis et al., 2013b). These exosomes are 
then internalized by neurons through endocytic pathway. Utilizing 
microfluidic chambers it was shown that exosomes were taken up by 
neurons at axonal and somatodendritic sites (Fruhbeis et al., 2013a). To 
unravel the bioactivity of exosomes, a Boyden chamber co-culture of 
neurons and oligodendrocytes was prepared. Neurons were subjected to 
oxidative stress and starvation via hydrogen peroxide and absence of 
B27 supplement respectively. These changes increased metabolic ac-
tivity in the presence of oligodendrocyte-derived exosomes suggesting 
that exosomes confer protection to neurons. The supportive role of 
oligodendroglial exosomes on neurons is not limited to neuroprotection. 
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Fröhlich et al. reported a broad spectrum of roles for 
oligodendrocyte-derived exosomes, which include activation of 
signaling pathways such as MEK/Erk and PI3K/Akt, neuronal gene 
expression, and enhancement of action potential, as well as resistance to 
oxidative stress and promotion of neuronal survival (Frohlich et al., 
2014). 
In addition to serving as initiating factor in myelination, neurons can 
also negatively regulate myelination. Bakhti et al. reported that oligo-
dendrocytes secrete exosome-like vesicles that has autoinhibitory effect 
on cell differentiation by reducing the cell surface expansion and sub-
sequently inhibiting myelination (Bakhti et al., 2011). Regarding the 
regulatory role of Rho-associated kinase (RhoA-ROCK) pathway in 
oligodendrocyte branching and cell surface expansion (Kippert et al., 
2009; Kippert et al., 2007; Liang et al., 2004), authors tested the effect of 
Rock inhibitor and Myosin II inhibitor on cell surface size. It was 
observed that such inhibitors prevented the negative regulatory effect of 
exosome-like vesicles on cell expansion. Thus, exosome-like vesicles 
inhibit cell surface size through the activation of Rho-ROCK-myosin 
signaling axis. Furthermore, incubation of oligodendrocytes with 
neuronal conditioned medium robustly reduced exosome release and 
therefore authors proposed the likelihood of one or more neuronal 
factors in neuronal conditioned medium that prevent the exosome 
secretion. Therefore, neuronal signals regulate myelin membrane 
biogenesis through controlling the exosome release. 
Oligodendrocytes have been shown to receive instructive signals 
-incorporated in exosomes- also from other cell types such as astrocytes 
and dendritic cells. For instance, it was observed that direct contact 
culture of OPC with astrocytes significantly enhanced exosome secretion 
and OPC proliferation (Zhang et al., 2020) when compared to OPC 
co-cultured with AST supernatant group. Transcriptome sequencing 
revealed a set of differentially expressed genes between the two groups 
among which was the upregulation of Integrin subunit Beta 4 (ITGB4), a 
protein which mediates cell adhesion suggesting an important role for 
ITGB4 in OPC proliferation. This was confirmed by ITGB4 gene knock-
down, which resulted in reduction of exosome release and proliferation 
rate. When exosomes were added to the ITGB4 deficient OPC/astrocyte 
co-culture proliferation rate was restored. It was therefore concluded 
that OPC proliferation is regulated by astrocytes through ITGB4 medi-
ated exosomal secretion. 
A considerable number of papers have highlighted the therapeutic 
effects of extracellular vesicles and exosomes in promoting oligoden-
drocytes proliferation and/or differentiation as well as remyelination 
and axon regeneration. For example, in prenatal brain injury, which 
affects white and gray matter and causes severe neurodevelopmental 
phenotypes, Mesenchymal stromal cell-derived exosomes were effective 
in rescuing myelination and reducing injuries of gray and white matter 
(Thomi et al., 2019). In another study, treatment with Mesenchymal 
stem cell-derived EVs in a rat model of preterm brain injuries efficiently 
ameliorated inflammation induced hypomyelination, neuronal cell 
degeneration and long-term white matter microstructural abnormalities 
(Drommelschmidt et al., 2017). With promising outcomes, environ-
mental enrichment (EE) also seems an effective treatment in improving 
brain function. EE is described as enhancement of physical, social and 
intellectual activity (Pusic et al., 2016). Exosomes have been found as 
one of the effective neuroprotection elements in EE (Pusic & Kraig, 
2014). Application of both young and EE-serum exosomes on 
Fig. 2. Schematic of exosome secretion, structure, and involvement during CNS development. The exosome cargos are sorted into early endosomes through either 
endocytosis, inward folding of plasma membrane, or directly from Golgi network (Palmulli & van Niel, 2018), a process that is mediated by the endosomal sorting 
complexes required for transport (ESCRT) machinery. Invagination of the late endosomes, also referred as Multivesicular bodies (MVBs), forms intraluminal vesicles 
(ILVs). These ILVs are eventually released as exosomes into extracellular space by fusion of MVBs with plasma membrane. The precise mechanism of release is not 
clear however, intracellular calcium and depolarization, mediated by glutamatergic synaptic activity, are indicated as triggers for exosome secretion. Some of the 
exosome contents are highlighted at each stages of CNS development. As it is shown, miRNAs are the most studied element of exosomes during neuro-gliogenesis. 
CAM kinase II alpha is suggested as one of the candidate cargos of synaptic exosome, a scenario which needs to be investigated (Smalheiser, 2007). Interestingly, 
exosomes actively involve in myelination mainly by transporting myelin related proteins between neurons and oligodendrocytes. 
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hippocampal slice culture, an in vitro myelination model, significantly 
increased OPCs proliferation. They were also effective in increasing the 
baseline levels of BMP, indicating that myelination is also increased. 
Analysis of miRNA expression profile identified miR-219 as the effective 
factor in such exosomes. Interestingly, miR-219 was also able to increase 
OPCs differentiation to myelinating oligodendrocytes. When exosomes 
derived from young rats were nasally administered in aging rats, a sig-
nificant myelination was observed in the motor cortex suggesting the 
regenerative therapeutic potential of such exosomes. Fig. 2 represents a 
summary of exosome secretion process and its contribution at each CNS 
developmental stage. 
8. Challenges and Future directions 
Despite a plethora of studies that have enlightened our understand-
ing of EVs’ biogenesis, structure and function, some fundamental and 
critical questions remain to be answered. For instance, there is still 
insufficient knowledge about the distinct roles of each subtype and the 
precise mechanisms that regulate their biogenetic pathways. Why are 
some EVs produced through the ESCRT-dependent pathway while 
others are generated by the ESCRT- independent pathway? And how 
does the biogenetic pathway of the parental cell affects the impact of the 
EV on a distant recipient cell? Such questions need in depth answers in 
order to understand the full paradigm of EVs in CNS development in 
physiology and pathology. Such understanding is also elementary to 
successful exploitation of EVs in therapeutic strategies to treat CNS 
disorders. There is an increasing interest in engineering EVs for thera-
peutic purposes; the success of such approach highly relies on basic 
understanding of the relationships between biogenesis, structure and 
function of natural EVs. 
Another challenge is posed by the fact that our current understand-
ing about EVs mainly stems from in vitro studies. It needs to be deter-
mined whether this knowledge is transferrable to the in vivo situation. 
Interestingly, it has recently been demonstrated that EVs released by 3D- 
culture systems differ from EVs released by 2D-culture systems, under-
scoring the impact of the microenvironment on the production of EVs 
(Rocha et al., 2019; Thippabhotla et al., 2019; Villasante et al., 2016). 
In vitro studies also lack a dynamic BBB posing a challenge on the 
exploitation of in vitro EV knowledge in designing strategies to treat CNS 
disorders. Although EVs are capable of crossing the BBB, the rate at 
which they pass such dynamic barrier in vivo might affect their treatment 
efficacy as determined in vitro. For instance, the study by Banks et al. 
showed that exosomes from different cell lines were able to pass the 
BBB, albeit at different rates and engaging different molecular transport 
mechanisms (Banks et al., 2020). 
Last but not least, designing successful EV-based strategies to treat 
CNS disorders requires consideration of a few complicating points. The 
brain is an intricate organization of neural and glial cells that displays 
regional differences in structure and function and most likely in EV 
repertoir and dynamics. Also, during CNS development in situ EV- 
properties probably vary in correspondence with developmental mile-
stones. Therefore, future investigations should also focus on the impact 
of the brain regional differences and the CNS developmental stages on 
EV structure and function and vice versa. Since the brain is a hard to 
access tissue such studies will certainly benefit from recent and future 
developments in the generation of human-derived brain organoids. 
9. Conclusion 
The current review surveys the enormous amount of research con-
ducted on the role of EVs in neural cell communication and highlights 
the fact that exosomes dynamically accompany neural cells throughout 
CNS development from initial stages such as neurogenesis and syn-
aptogenesis to the final steps when cells are fully functional. 
EVs are appreciated as vehicles carrying messages to which recipient 
cells respond. The messages are composed by the parental cell and vary 
with its genotype, phenotype and microenvironment. Reciprocity 
involving neural and non-neural cells makes this membrane- 
encapsulated communication system apt to orchestrate dynamics of 
the developing and adult brain. We are just beginning to understand the 
complexity of EV-mediated communication in CNS. On the basis of 
current knowledge, we already see opportunities to utilize EVs for 
diagnosis and therapy of CNS disorders. For example, the onset of autism 
spectrum disorders and Rett syndrome begins approximately below the 
age of two when synaptogenesis and neuro-gliogenesis are occurring. 
EVs offer a promising therapeutic avenue to instruct these geneses to 
develop normally. More research is needed to fully understand this 
intricate communication system of the brain and to become able to 
exploit clinically its diagnostic and therapeutic potentials. 
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